Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/4/25 16:21 | 9/3/25 | EDIT | Health | BioPrd | Biological Products, (No Diag | Burkly Linda | MA | O | EVP,CHIE | 5 | S | -85 | 3.99 | 0 | -21 | 73 | D | |||||||||||||||
9/4/25 16:20 | 9/3/25 | EDIT | Health | BioPrd | Biological Products, (No Diag | Parison Amy | MA | O | SVP,CFO | 3 | S | -4 | 2.34 | 0 | -2 | 18 | D | |||||||||||||||
9/4/25 16:20 | 9/3/25 | EDIT | Health | BioPrd | Biological Products, (No Diag | O'Neill Gilmore Neil | MA | DO | CEO | 6 | S | -145 | 2.74 | 0 | -53 | 315 | D | |||||||||||||||
3/5/25 16:44 | 3/4/25 | EDIT | Health | BioPrd | Biological Products, (No Diag | Lucera Erick | MA | O | EVP,CFO | 2 | S | -132 | 5.01 | 0 | -26 | 117 | D | |||||||||||||||
12/5/24 16:37 | 12/3/24 | EDIT | Health | BioPrd | Biological Products, (No Diag | Mei Baisong | MA | O | EVP,CHIE | 4 | S | -40 | 4.90 | 0 | -8 | 141 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |